Hiroshi Kawabe
Director/Board Member at ASTELLAS PHARMA INC.
Network origin in Hiroshi Kawabe first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 47 | |
Foundation for Promotion of Medical Training
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hiroshi Kawabe via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
| PIONEER CORP | Electronic Production Equipment | Director of Finance/CFO | |
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | Chairman Director/Board Member | |
| KAO CORPORATION | Household/Personal Care | Director/Board Member | |
| JSR CORPORATION | Semiconductors | Director/Board Member | |
| HITACHI KOKI CO., LTD. | Electrical Products | Comptroller/Controller/Auditor | |
| INABATA & CO.,LTD. | Wholesale Distributors | Director/Board Member | |
| TAMURA CORPORATION | Electronic Components | Director/Board Member | |
| NICHIREKI CO., LTD. | Engineering & Construction | Director/Board Member | |
| Keio University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Arizona State University | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Masters Business Admin | |
| Waseda University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Chief Executive Officer President General Counsel Corporate Officer/Principal | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Phrama Inc founded in 2000. The firm is headquartered in Brisbane, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Chief Investment Officer | |
| University of Hitotsubashi | College/University | Masters Business Admin | |
| University of Tokyo | College/University | Graduate Degree Doctorate Degree | |
| FREEBIT CO., LTD. | Internet Software/Services | Founder | |
| Kyoto University | College/University | Graduate Degree | |
| Kanazawa University | College/University | Doctorate Degree | |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| SKYLARK HOLDINGS CO., LTD. | Restaurants | Director of Finance/CFO | |
| The U.S.-Japan Business Council, Inc. | Director/Board Member | ||
Fanatics LLC
 Fanatics LLC Internet Software/ServicesTechnology Services Fanatics LLC retails sports apparel and merchandise. Its brands include Nike, Adidas, Under Armour, Fanatics, Starter, Kitbag, Majestic and Columbia. The company was founded by Alan S. Trager, Michael Rubin, and Mitchell Trager in 2002 and is headquartered in Jacksonville, FL. | Internet Software/Services | Chief Tech/Sci/R&D Officer | |
| Washington Biotechnology & Biomedical Association | Director/Board Member | ||
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer General Counsel | |
Dow Corning Holding Japan KK
 Dow Corning Holding Japan KK Financial ConglomeratesFinance Part of Dow, Inc., Dow Corning Holding Japan KK is an investment holding Japanese company. | Financial Conglomerates | President | |
Dow Corning Toray Co. Ltd.
 Dow Corning Toray Co. Ltd. Industrial SpecialtiesProcess Industries Part of Dow, Inc., Dow Corning Toray Co. Ltd. is a Japanese company that manufactures rubber, chemical and film products. The private company is based in Tokyo, Japan. Eriko Sakurai has been the CEO of the company since 2008. | Industrial Specialties | Chief Executive Officer | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
| Homma & Partners | Corporate Officer/Principal | ||
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Halo-Bio RNAi Therapeutics, Inc.
 Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Halo-Bio RNAi Therapeutics, Inc. utilizes the novel 'Multivalent RNAi Platform' to develop multi-gene targeting products for the treatment of disease. The firm specializes in RNAi, Biopharmaceuticals, RNA Delivery and Nanoparticles. The company is headquartered in Seattle, WA. | Biotechnology | Founder | |
Mitobridge, Inc.
 Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Biotechnology | President | |
| AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kyushu University Faculty of Law | College/University | Graduate Degree | |
DigiTx Partners LLC
 DigiTx Partners LLC Investment ManagersFinance DigiTx Partners LLC (DigiTx Partners) is a venture capital firm founded in 2016 by David J. Kim and Luke Evnin. The firm is headquartered in Brisbane, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Cci France International | Director/Board Member | ||
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h Ltd (O2h) is a venture capital firm. The firm is founded by Sunil and Prashant Shah. It is headquartered in United Kingdom. | Investment Managers | Private Equity Investor | |
| Ecole Des Ponts Business School | College/University | Masters Business Admin | |
| ENTRADA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Universite Paris Cite | College/University | Doctorate Degree | |
Nanna Therapeutics Ltd.
 Nanna Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | President | |
| Astellas Innovation Management LLC | Corporate Officer/Principal | ||
Solu Therapeutics
 Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| Japan | 23 |
| United States | 22 |
| United Kingdom | 4 |
| France | 4 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 13 |
| Finance | 6 |
| Electronic Technology | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 89 |
| Corporate Officer/Principal | 47 |
| President | 21 |
| Chairman | 19 |
| Independent Dir/Board Member | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Nobuaki Tanaka | 20 |
| Percival Barretto-Ko | 15 |
| Claudia Mitchell | 12 |
| Yasuo Ikeda | 12 |
| Hikaru Saito | 10 |
| Tatsuro Ishizuka | 9 |
| Eriko Sakurai | 7 |
| Mamoru Sekiyama | 6 |
| Bernhardt Zeiher | 6 |
| Satoshi Konagai | 6 |
| Haruko Shibumura | 6 |
| Kenji Yasukawa | 5 |
| David Barrett | 5 |
| Jeffrey Ludwig | 4 |
| Adam John Pearson | 4 |
- Stock Market
- Insiders
- Hiroshi Kawabe
- Company connections
